210 results
Page 3 of 11
424B2
vcli8v
29 May 20
Prospectus for primary offering
6:07am
424B5
w7jcq0k hz3
27 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-10.2
rqv2wcc12ehk7eflnv6
13 May 20
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
t82r8r 4v9y851bd
13 May 20
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
oh17h5wn
5 Mar 20
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930
7:24am
424B5
52r1vtxmkz4oc
21 Nov 19
Prospectus supplement for primary offering
9:06am
424B2
5inyii6 lq
14 Nov 19
Prospectus for primary offering
5:25pm
424B5
j3bu3bs3u7x7b
12 Nov 19
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
x3ekgswtmiyou4o1yi8w
28 Oct 19
BioCryst Reports Data From Phase 1 Trial of BCX9930 and Announces Plans to Advance Program Into Proof of Concept Study in PNH Patients
7:37am